A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: The Anglo–Danish–Dutch Study of Intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe) study

Rebecca K. Simmons, Knut Borch-Johnsen, Torsten Lauritzen, Guy E.H.M. Rutten, Annelli Sandbæk, Maureen Van Den Donk, James A. Black, Libo Tao, Edward C.F. Wilson, Melanie J. Davies, Kamlesh Khunti, Stephen J. Sharp, Nicholas J. Wareham, Simon J. Griffin*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: The Anglo–Danish–Dutch Study of Intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe) study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Medicine and Dentistry